Clinical Trial Update: Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of ASP1948 in Japanese patients with locally advanced or metastatic solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ASP1948

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies | Phase 1 | Status: COMPLETED